by Rachel LaBreck | Mar 8, 2025 | News
The BeVigilant™ OraFusion™ System was recently recognized by Inside Dentistry as one of the “10 Dental Technologies That Inspire for 2025.” The article spotlights our innovative, saliva-based test that enables early detection of oral cancer biomarkers right from the...
by Rachel LaBreck | Dec 20, 2024 | News
Breaking Cancer News dives into how Vigilant Biosciences® is advancing the early detection of oral cancer with its BeVigilant™ OraFusion™ System. The article features insights from oral surgeon Dr. William Shepard, who shares how this biomarker-driven saliva test is...
by Rachel LaBreck | Jun 25, 2024 | News
Dental Economics recently featured Vigilant Biosciences® and our BeVigilant™ OraFusion™ System in an article highlighting advancements in early oral cancer detection. The OraFusion System is a real-time, saliva-based test that enables dental professionals to identify...
by Rachel LaBreck | Jun 10, 2024 | News
We’re thrilled to see the BeVigilant™ OraFusion™ System featured in DSOPro as a key innovation shaping the future of DSOs. The article highlights how the BeVigilant™ OraFusion™ System enables clinicians to detect early signs of oral cancer in real-time, right from the...
by Rachel LaBreck | May 3, 2024 | News
We’re excited to see Dental Products Report highlight the BeVigilant™ OraFusion™ System as a powerful advancement in oral cancer detection. The article dives into how our technology leverages salivary biomarkers and AI to deliver real-time results chairside—giving...
by dex.manley | Nov 15, 2023 | News
Lifestyle factors play a major role in the development of oral cancer. Among the many clinical risk factors, smoking and alcohol top the list of behaviors that most directly increase a patient’s risk of oral cancer. Alone, smoking increases oral cancer risk by ten...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES